Verve Therapeutics, Inc.

Ownership Transactions Reported by 38 Insiders

Symbol
VERV on Nasdaq
Industry
Pharmaceutical Preparations
Location
201 Brookline Avenue, Suite 601, Boston, MA

Insiders trading volume in the past year

Verve Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Krishna Yeshwant Director, 10%+ Owner $122M +$18M +17.4% Jun 26, 2024
Gv 2017 Gp, L.L.C. Member of 10% Group $104M Nov 4, 2022
Gv 2019 Gp, L.L.C. 10%+ Owner $44.7M Jun 21, 2021
ARCH Venture Partners X, LLC 10%+ Owner $25.1M Jun 21, 2021
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10%+ Owner $25M Jun 21, 2021
Casdin Partners Master Fund, L.P. 10%+ Owner $24.2M Jun 21, 2021
Redmile Group, LLC 10%+ Owner $19.4M Jun 21, 2021
Gv 2023 Gp, L.L.C. Member of 10% Group $18M Dec 1, 2023
Cormorant Asset Management, LP Former 10% Owner $9.84M Jun 21, 2021
Logos Global Management LP 10%+ Owner $8.13M Jun 21, 2021
Broad Institute, Inc. 10%+ Owner $8.1M Jun 21, 2021
Holdings A/S Novo 10%+ Owner $7.93M Jun 21, 2021
Casdin Private Growth Equity Fund, L.P. 10%+ Owner $6.21M Jun 21, 2021
Fmr Llc Other* $5.71M Jul 26, 2022
Beam Therapeutics Inc. 10%+ Owner $5.47M Jun 21, 2021
Burt A. Adelman Director $4.28M Jun 26, 2024
Israel Rozen 10%+ Owner $4.1M Jun 16, 2021
Barry Ticho 10%+ Owner $4.1M Jun 16, 2021
Jae Keith Joung 10%+ Owner $4.1M Jun 16, 2021
Sekar Kathiresan Chief Executive Officer, Director $3.25M Jun 28, 2024
Andrew Ashe President, Chief Operating Officer $2.5M +$476K +23.5% May 14, 2024
Rock Springs Capital Management LP 10%+ Owner $1.53M Jun 21, 2021
Allison Dorval Chief Financial Officer $491K -$6.34K -1.28% Feb 14, 2024
Andrew Bellinger Chief Scientific Officer $450K Feb 14, 2024
Fred T. Fiedorek Chief Medical Officer $220K Feb 14, 2024
Joan Nickerson Chief Administrative Officer $171K -$12.5K -6.81% Apr 1, 2024
Jason Politi Chief Technical Ops. Off. $39.2K Jun 26, 2024
Troy Lister Chief Scientific Officer $11.3K Jun 21, 2024
Margaret Beaudoin Vice President, Finance $10K Jun 17, 2021
Sheila Mikhail Director Jun 26, 2024
John M. Evans Director Jun 9, 2022
Alexander Cumbo Director Jun 26, 2024
Michael F. MacLean Director Jun 26, 2024
Lonnel Coats Director Jun 26, 2024
Ourania Tatsis Director Jun 26, 2024
Jodie Pope Morrison Director Jun 26, 2024
ARCH Venture Fund X, L.P. 10%+ Owner Jun 16, 2021
Biomatics Capital Partners, L.P. 10%+ Owner Jun 16, 2021

Recent Insider Transactions by Companies or Individuals for Verve Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.